Barrett Katz, Chief Medical Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 58,000 shares at $37.21 ($2.2M) on 2023-01-17, disclosed to the SEC on 2023-01-18.
Open-market sale of $2.2M VRDN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.01 | 4,147 | $153K | 7.1% |
| 2 | $37.01 | 4,147 | $153K | 7.1% |
| 3 | $37.21 | 24,853 | $925K | 42.9% |
| 4 | $37.21 | 24,853 | $925K | 42.9% |
| Total | $37.18 avg | 58,000 | $2.2M | 100% |